<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00792857</url>
  </required_header>
  <id_info>
    <org_study_id>CTAP201-CL-1007</org_study_id>
    <nct_id>NCT00792857</nct_id>
  </id_info>
  <brief_title>Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)</brief_title>
  <official_title>Single-Dose, Two-Period, Open Label, Dose Determination, Randomized, Cross-Over Study of CTAP201 Injection and Doxercalciferol (Hectorol) Injection in Subjects With Stage 5 CKD and SHPT on Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OPKO IP Holdings II, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>OPKO Health, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare CTAP201 with Doxercalciferol in patients with chronic kidney disease
      (CKD) and secondary hyperparathyroidism (SHPT), undergoing regular hemodialysis, at different
      dose strengths. This study will also investigate the levels of CTAP201 in the body over time
      and determine the safety of CTAP201.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood levels of CTAP201 and doxercalciferol</measure>
    <time_frame>Day 1 and Day 15 of each dose level</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety of a single dose of CTAP201 Injection</measure>
    <time_frame>Throughout the study</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>Secondary Hyperparathyroidism</condition>
  <condition>Chronic Renal Insufficiency</condition>
  <condition>Chronic Renal Failure</condition>
  <arm_group>
    <arm_group_label>CTAP201 Injection at dose a</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CTAP201 at dose a</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CTAP201 Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CTAP201 at dose b or dose c</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Doxercalciferol at dose a</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active at dose a</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Doxercalciferol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active at dose b or dose c</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CTAP201 Injection</intervention_name>
    <description>Comparison of different dose strengths of CTAP201 after single dose.</description>
    <arm_group_label>CTAP201 Injection at dose a</arm_group_label>
    <arm_group_label>CTAP201 Injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Doxercalciferol</intervention_name>
    <description>Comparison of different dose strengths of doxercalciferol after single dose.</description>
    <arm_group_label>Doxercalciferol at dose a</arm_group_label>
    <arm_group_label>Doxercalciferol</arm_group_label>
    <other_name>Hectorol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index between 18 and 40

          -  On maintenance hemodialysis three times per week

          -  Visit 1: Serum iPTH value greater than or equal to 200 pg/mL and lower than or equal
             to 1000 pg/mL

          -  Visit 1: Serum total calcium value greater than 8.4 mg/dL and lower than 10.0 mg/dL

          -  Visit 1: Serum phosphorus value greater than or equal to 2.5 mg/dL and lower than or
             equal to 5.5 mg/dL

          -  Serum 25-hydroxyvitamin D level greater than or equal to 15 ng/mL

          -  Visit 2: Serum iPTH value greater than 300 pg/mL

          -  Visit 2: Serum Ca x P product less than 56 [mg/dl]2

          -  Willing and able to discontinue vitamin D and/or bone metabolism therapy for at least
             2 weeks prior to administration of Study Drug, and length of study

        Exclusion Criteria:

          -  Taking cytochrome P450 3A inhibitors and/or inducers

          -  Abnormal liver functions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Melnick, MD</last_name>
    <role>Study Director</role>
    <affiliation>OPKO Renal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pivotal Reseach Centers</name>
      <address>
        <city>Peoria</city>
        <state>Arizona</state>
        <zip>85381</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western New England Renal and Transplant Associates</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Clinical Research</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103-6379</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Houston Research Ltd.</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77099</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2008</study_first_submitted>
  <study_first_submitted_qc>November 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2008</study_first_posted>
  <last_update_submitted>September 26, 2014</last_update_submitted>
  <last_update_submitted_qc>September 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parathyroid Diseases</keyword>
  <keyword>Renal Insufficiency</keyword>
  <keyword>Kidney Failure, Chronic</keyword>
  <keyword>Hyperparathyroidism, Secondary</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Hyperparathyroidism</keyword>
  <keyword>Renal Insufficiency, Chronic</keyword>
  <keyword>Kidney Diseases</keyword>
  <keyword>Kidney Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Hyperparathyroidism</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Hyperparathyroidism, Secondary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>1 alpha-hydroxyergocalciferol</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

